Posted Apr. 3, 2012 at 11:16 a.m.

Premium Lock GSK to move ahead with experimental diabetes drug

Published: 2012-04-03 11:16:31
Updated: 2012-04-03 11:16:31

Diabetes   Diabetes

The proposed once-weekly injectable albiglutide would offer a dosing advantage to the once-daily Novo Nordisk injectable drug Victoza....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders